HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Peginterferon and ribavirin treatment for hepatitis C virus infection.

Abstract
Pegylated interferon α (IFNα) in combination with ribavirin is currently recommended as a standard-of-care treatment for chronic hepatitis C virus (HCV) infection. This combination therapy has drastically improved the rate of sustained virological response, specifically in difficult-to-treat patients. Recently, individualized treatment, such as response-guided therapy, is being developed based on host-, HCV- and treatment-related factors. Furthermore, modified regimens with currently available medications, novel modified IFNα and ribavirin or combinations with specifically targeted antiviral therapy for HCV agents, are currently being investigated. The purpose of this review is to address some issues and epoch-making topics in the treatment of chronic HCV infection, and to discuss more optimal and highly individualized therapeutic strategies for HCV-infected patients.
AuthorsAkihito Tsubota, Kiyotaka Fujise, Yoshihisa Namiki, Norio Tada
JournalWorld journal of gastroenterology (World J Gastroenterol) Vol. 17 Issue 4 Pg. 419-32 (Jan 28 2011) ISSN: 2219-2840 [Electronic] United States
PMID21274371 (Publication Type: Journal Article, Review)
Chemical References
  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • RNA, Viral
  • Recombinant Proteins
  • Polyethylene Glycols
  • Ribavirin
  • peginterferon alfa-2b
  • peginterferon alfa-2a
Topics
  • Antiviral Agents (therapeutic use)
  • Disease Progression
  • Genotype
  • Hepacivirus (genetics)
  • Hepatitis C, Chronic (drug therapy, pathology, physiopathology)
  • Humans
  • Interferon alpha-2
  • Interferon-alpha (therapeutic use)
  • Liver Cirrhosis (drug therapy, pathology, physiopathology)
  • Polyethylene Glycols (therapeutic use)
  • RNA, Viral
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Ribavirin (analogs & derivatives, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: